0001209191-18-047055.txt : 20180816 0001209191-18-047055.hdr.sgml : 20180816 20180816162624 ACCESSION NUMBER: 0001209191-18-047055 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180814 FILED AS OF DATE: 20180816 DATE AS OF CHANGE: 20180816 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cooper Ronald Harold Wilfred CENTRAL INDEX KEY: 0001676880 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33451 FILM NUMBER: 181023603 MAIL ADDRESS: STREET 1: C/O GENOCEA BIOSCIENCES, INC. STREET 2: 100 ACORN PARK DRIVE, 5TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02140 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALBIREO PHARMA, INC. CENTRAL INDEX KEY: 0001322505 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10 POST OFFICE SQUARE STREET 2: SUITE 502 SOUTH CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 857-415-4774 MAIL ADDRESS: STREET 1: 10 POST OFFICE SQUARE STREET 2: SUITE 502 SOUTH CITY: BOSTON STATE: MA ZIP: 02109 FORMER COMPANY: FORMER CONFORMED NAME: Biodel Inc DATE OF NAME CHANGE: 20050331 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-08-14 0 0001322505 ALBIREO PHARMA, INC. ALBO 0001676880 Cooper Ronald Harold Wilfred C/O ALBIREO PHARMA INC. 10 POST OFFICE SQUARE, SUITE 502 SOUTH BOSTON MA 02109 1 1 0 0 President and CEO Common Stock 2018-08-14 4 P 0 588 31.63 A 6534 D Common Stock 2018-08-14 4 P 0 200 32.50 A 6734 D The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2018. This transaction was executed in multiple trades at prices ranging from $31.39 to $31.83. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. /s/ Jason Duncan, Attorney-in-fact 2018-08-16